Recombination-based DNA assembly methods and compositions

By assembling multiple double-stranded DNA fragments into covalently bound circular DNA molecules using a reaction mixture of exonuclease and recombinase, the complexity of DNA assembly in the prior art is solved by assembling multiple double-stranded DNA fragments into covalently bound circular DNA molecules and transforming and replicating in host cells. The problems of high and low efficiency achieve efficient and low-cost DNA assembly effect.

CN119032178APending Publication Date: 2024-11-26INTEGRATED DNA TECHNOLOGIES INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380027504.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-01-31
Filing Date
2023-01-30
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The existing nucleic acid recombination technology has problems of high complexity, low efficiency and high cost in the DNA assembly process, and it is difficult to effectively assemble multiple double-stranded DNA fragments to form longer covalently bound circular DNA molecules.

Method used

Using a reaction mixture containing exonuclease and recombinase, multiple double-stranded DNA fragments are incubated through hybridization and inactivation to form covalently bound circular DNA molecules, and transform and replicate in competent host cells, using recombinase For example, RecA or T5 exonuclease promotes complementary base pairing at the ends of single-stranded DNA, combining ATP and crowding reagents such as PEG to improve assembly efficiency.

Benefits of technology

It significantly reduces the complexity and cost of the DNA assembly process, improves assembly efficiency and fidelity, and can stably assemble and replicate multiple double-stranded DNA fragments in E. coli cells to form covalently bound circular DNA molecules.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure FT_3
    Figure FT_3
Patent Text Reader

Abstract

Described herein are compositions and methods for assembly based on recombinant long dsDNA molecules. One embodiment described herein is a method of creating a large recombinant plasmid in a competent host cell using a recombinase and an exonuclease using a plurality of double-stranded DNA fragments containing overlapping fragments.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] Cross-references to related applications

[0002] This application claims priority to U.S. Provisional Patent Application No. 63 / 304,792, filed on January 31, 2022, which is incorporated herein by reference in its entirety.

[0003] Sequence Listing References

[0004] This application submits a sequence listing XML in ST.26 XML format according to 37 CFR § 1.831. The sequence listing XML file "013670-0012-WO01_sequence_listing_xml_18-JAN-2023.xml" submitted to the USPTO Patent Center was created on January 18, 2023, contains 22 sequences, and has a file size of 45.6 K bytes. The file is incorporated into this specification by reference in its entirety. Technical Field

[0005] Compositions and methods for recombination-based assembly of long dsDNA molecules are described herein. One embodiment described herein is a method for creating large recombinant plasmids in competent host cells using multiple double-stranded DNA fragments containing overlapping fragments using a recombinase and an exonuclease. Background Art

[0006] Nucleic acid recombination is at the core of molecular biology and biotechnology. The efficiency with which recombinant nucleic acid technology is achieved can determine the outcome of certain biotechnological implementations. The ability to perform DNA assembly, or the ability to physically link multiple double-stranded DNA (dsDNA) fragments together to create longer dsDNA fragments, is a key technology in synthetic biology.

[0007] What are needed are methods and compositions that overcome existing challenges of current nucleic acid recombinant technology, reduce the complexity of the process, and increase DNA assembly efficiency and fidelity while reducing overall assembly costs. Summary of the invention

[0008] One embodiment described herein is a method for assembling multiple double-stranded DNA (dsDNA) fragments into covalently bound circular dsDNA molecules, the method comprising: (a) combining multiple different dsDNA fragments with a reaction mixture comprising an exonuclease and a recombinase to form a DNA reaction mixture; wherein each individual dsDNA fragment comprises one or more terminal single-stranded nucleotides complementary to the terminal single-stranded nucleotides of the independent dsDNA fragment; (b) hybridizing and incubating the DNA reaction mixture to form a hybrid DNA reaction mixture; (c) incubating the hybrid DNA reaction mixture to form an inactivated DNA reaction mixture; (d) transforming the inactivated DNA reaction mixture into a competent host cell; and (e) incubating the transformed competent host cell under conditions sufficient to assemble and replicate one or more covalently bound circular dsDNA molecules comprising the multiple different dsDNA fragments. In one aspect, the recombinase is selected from Uvsx from bacteriophage, Rad51 or Dmc1 from eukaryotes, RadA from archaea, or RecA from Escherichia coli (E. coli). In another aspect, the recombinase is RecA from Escherichia coli. In another aspect, the reaction mixture further comprises ATP. In another aspect, the exonuclease is T5 exonuclease. In another aspect, the reaction mixture further comprises a DNA polymerase and a ligase. In another aspect, the competent host cell is an Escherichia coli cell. In another aspect, the complementary one or more terminal single-stranded nucleotides overlap the terminal single-stranded nucleotides of the independent dsDNA fragments by about 10 nucleotides to about 120 nucleotides. In another aspect, the complementary one or more terminal single-stranded nucleotides overlap the terminal single-stranded nucleotides of the independent dsDNA fragments by about 20 nucleotides to about 60 nucleotides. In another aspect, the complementary one or more terminal single-stranded nucleotides overlap the terminal single-stranded nucleotides of the independent dsDNA fragments by about 20 nucleotides to about 35 nucleotides. In another aspect, the complementary one or more terminal single-stranded nucleotides overlap the terminal single-stranded nucleotides of the independent dsDNA fragments by about 25 nucleotides to about 30 nucleotides. In another aspect, the hybridization incubation includes a hybridization temperature of about 25°C to about 50°C for about 5 minutes to about 120 minutes. In another aspect, the hybridization incubation comprises a hybridization temperature of about 35°C to about 45°C for about 10 minutes to about 20 minutes. In another aspect, the hybridization incubation comprises a hybridization temperature of about 42°C for about 20 minutes. In another aspect, the inactivation incubation comprises an inactivation temperature of about 60°C to about 70°C for about 5 minutes to about 120 minutes. In another aspect, the inactivation incubation comprises an inactivation temperature of about 65°C for about 20 minutes. In another aspect, the inactivation incubation comprises an inactivation temperature of less than about 5°C for about 20 minutes.In another aspect, the reaction mixture further comprises one or more crowding agents, one or more chaperones, or a combination thereof. In another aspect, the one or more crowding agents comprise polyethylene glycol (PEG). In another aspect, the one or more chaperones comprise a diol or polyol selected from the group consisting of substituted linear or branched alkylene glycols, pentaerythritol, sorbitol, diethylene glycol, dipropylene glycol, neopentyl glycol, propylene glycol and glycol ethers, 1,2-ethylene glycol, 1,2-PrD, 1,3-PrD, 1,4-butanediol, 1,5-pentanediol, 1,6-hexanediol, 2-methyl-1,3-propanediol, 2,2′-dimethylpropylene glycol, 1,3-butylethylpropylene glycol, methylpropylene glycol, methylpentanediol, propylene glycol methyl ether, propylene glycol ethyl ether, propylene glycol butyl ether, diethylene glycol phenyl ether, propylene glycol phenol ether, propylene glycol methyl ether, tripropylene glycol methyl ether, propylene glycol isobutyl ether, ethylene glycol methyl ether, or a combination thereof. In another aspect, the method further comprises isolating the covalently bound circular dsDNA molecules comprising the plurality of different dsDNA fragments from one or more competent host cells. In another aspect, the method further comprises sequencing the covalently bound circular DNA molecules comprising the plurality of different dsDNA fragments after isolating from the competent host cells.

[0009] Another embodiment described herein is a system for assembling multiple double-stranded DNA (dsDNA) fragments into covalently bound circular DNA molecules, the system comprising: (a) multiple different dsDNA fragments, wherein each individual dsDNA fragment comprises one or more terminal single-stranded nucleotides complementary to the terminal single-stranded nucleotides of the dsDNA fragments independent of the multiple different dsDNA fragments; (b) a reaction mixture comprising a nuclease and a recombinase; and (c) a competent host cell. On the other hand, the recombinase is selected from Uvsx from a bacteriophage, Rad51 or Dmc1 from a eukaryote, RadA from an archaea, or RecA from Escherichia coli. On the other hand, the recombinase is RecA from Escherichia coli. On the other hand, the reaction mixture further comprises ATP. On the other hand, the nuclease is T5 exonuclease. On the other hand, the reaction mixture further comprises a DNA polymerase and a ligase. On the other hand, the competent host cell is an Escherichia coli cell. On the other hand, the reaction mixture further comprises one or more crowding agents, one or more chaperones, or a combination thereof.

[0010] Another embodiment described herein is a kit for assembling multiple double-stranded DNA (dsDNA) fragments into covalently bound circular DNA molecules, the kit comprising: (a) an exonuclease; (b) a recombinase; (c) one or more buffers, crowding agents, or chaperones, or ATP; (d) optionally, a competent host cell; and (e) optionally, instructions or directions for use.

[0011] Another embodiment described herein is the use of exonucleases and recombinases for assembling multiple double-stranded DNA (dsDNA) fragments into covalently bound circular DNA molecules, comprising: (a) combining multiple different dsDNA fragments with a reaction mixture comprising an exonuclease and a recombinase to form a DNA reaction mixture, wherein each individual dsDNA fragment comprises one or more terminal single-stranded nucleotides complementary to the terminal single-stranded nucleotides of a dsDNA fragment independent of the multiple different dsDNA fragments; (b) incubating the DNA reaction mixture for hybridization to form a hybrid DNA reaction mixture; (c) incubating the hybrid DNA reaction mixture for inactivation to form an inactivated DNA reaction mixture; (d) transforming the inactivated DNA reaction mixture into a competent host cell; and (e) incubating the transformed competent host cell under conditions sufficient to assemble covalently bound circular DNA molecules comprising the multiple different dsDNA fragments. BRIEF DESCRIPTION OF THE DRAWINGS

[0012] Figure 1A-1B The assembly process of dsDNA oligonucleotides is shown. Figure 1A A scheme for assembly using exonucleases and recombinases is shown. Figure 1B The process of assembly using exonucleases, recombinases, ligases, and polymerases is shown.

[0013] Figure 2A-2B A schematic diagram of the assembly of dsDNA oligonucleotides is shown. Figure 2A Assembly using exonucleases and recombinases is shown (eg Figure 1A shown). Figure 2B Assembly using exonucleases, recombinases, ligases, and polymerases is shown (eg, Figure 1B shown).

[0014] Figure 3 Shown are total colony counts for the indicated reaction mix assembly compositions, incubated with dsDNA fragments, and subsequently transformed into appropriate host cells. Error bars represent standard deviation.

[0015] Figure 4Fluorescent colony counts are shown for the indicated reaction mix assembly compositions, incubated with dsDNA fragments, and subsequently transformed into appropriate host cells. Error bars represent standard deviation.

[0016] Figure 5 Shown are the percentages of fluorescent colonies in the total colony counts of the indicated reaction mix assembly compositions that were incubated with dsDNA fragments and subsequently transformed into appropriate host cells. Error bars represent standard deviations.

[0017] Figure 6 Fluorescent colony counts are shown for the indicated reaction mix assembly compositions incubated with dsDNA fragments with and without heat denaturation and then transformed into appropriate host cells. Error bars represent standard deviation.

[0018] Figure 7 Shown are fluorescent colony counts using recombinase and exonuclease reaction mixtures incubated with dsDNA at the indicated temperatures and subsequently transformed into appropriate host cells. Error bars represent standard deviations.

[0019] Figure 8 Shown are fluorescent colony counts using recombinase and exonuclease reaction mixtures incubated with dsDNA having the indicated sequence homology lengths and subsequently transformed into appropriate host cells. Error bars represent standard deviations. DETAILED DESCRIPTION

[0020] Unless otherwise defined, all technical and scientific terms used herein have the same meanings as those of ordinary skill in the art are generally understood. For example, any nomenclature and technology related to biochemistry, molecular biology, immunology, microbiology, genetics, cell and tissue culture, and protein and nucleic acid chemistry described herein are well known in the art and commonly used. In the event of a conflict, the present disclosure (including definitions) shall prevail. Exemplary methods and materials are described below, although methods and materials similar or equivalent to the methods and materials described herein can be used to practice or test embodiments and aspects described herein.

[0021] As used herein, the terms "amino acid", "nucleotide", "polynucleotide", "vector", "polypeptide" and "protein" have their common meanings as understood by those of ordinary biochemist in the art. Standard single-letter nucleotides (A, C, G, T, U) and standard single-letter amino acids (A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W or Y) are used herein.

[0022] As used herein, terms such as "comprising," "containing," "having," and the like mean "including." The present disclosure also contemplates other embodiments that "comprising," "consisting of," and "consisting essentially of" embodiments or elements presented herein, whether explicitly stated or not.

[0023] As used herein, unless otherwise indicated herein or clearly contradicted by the context, the terms "a", "an", "the" and similar terms used in the context of the present disclosure (especially in the context of the claims) will be deemed to cover both the singular and the plural. In addition, unless otherwise indicated, "a", "an" or "the" means "one or more", "one or more".

[0024] As used herein, the term "or" can be conjunctive or disjunctive.

[0025] As used herein, the term "substantially" means to a large or significant extent, but not completely.

[0026] As used herein, the term "about" or "approximately" as applied to one or more values ​​of interest refers to a value similar to the reference value or a value within an acceptable error range of a specific value as determined by a person of ordinary skill in the art, which will depend in part on how to measure or determine the value, such as the limitations of the measurement system. In one aspect, the term "about" refers to any value within a variation of up to ± 10% of the value modified by the term "about", including integers and fractional components. Alternatively, according to the practice of the art, "about" can mean within 3 or more standard deviations. Alternatively, for example, with respect to a biological system or process, the term "about" can mean within an order of magnitude of a value, within 5 times of a value in some embodiments, and within 2 times of a value in some embodiments. As used herein, the symbol "~" means "about" or "approximately".

[0027] All ranges disclosed herein include endpoints as discrete values, and all integers and fractions specified in the range. For example, the range of 0.1-2.0 includes 0.1, 0.2, 0.3, 0.4, ..., 2.0. If the endpoint is modified by the term "about", the specified range will be expanded (including the endpoint) with a change of up to ± 10% or 3 or more standard deviations of any value in the range.

[0028] As used herein, the terms "control" or "reference" are used interchangeably herein. A "reference" or "control" level can be a predetermined value or range used as a baseline or benchmark for evaluating measurement results. "Control" also refers to a control experiment or a control cell.

[0029] As used herein, the term "inhibit" refers to the reduction or suppression of a given biological process, disorder, symptom, condition or disease, or a significant decrease in the baseline activity of a biological activity or process.

[0030] As used herein, the phrase "room temperature," "RT," or "ambient temperature" indicates a temperature of about 20-27°C, about 25°C ± 10%; or ~25°C, at standard atmospheric pressure.

[0031] As used herein, the term "additive" refers to one or more components added to the buffers described herein to enhance hybridization and improve overall specificity.

[0032] As used herein, the term "nucleic acid" may refer to DNA, RNA, dsDNA, dsRNA, ssDNA, ssRNA, or a DNA / RNA complex or hybrid of sequences obtained from any source containing a target sequence and a non-target sequence. For example, a nucleic acid sample may be obtained from an artificial source or by chemical synthesis, or by enzymatic synthesis, or from a virus, a prokaryotic cell (including a microorganism), or a eukaryotic cell. A biological sample may be a vertebrate (including or excluding a human), an invertebrate, a plant, a microorganism, a virus, a mycoplasma, a fungus, or an archaea.

[0033] As used herein, the term "base pair" or "bp" refers to one or more nucleotides in a single-stranded nucleic acid molecule interacting with one or more nucleotides in a complementary single-stranded nucleic acid molecule via hydrogen bonding to form a double-stranded nucleic acid molecule (e.g., double-stranded DNA). The base pair can be a Watson-Crick, Hoogsteen or other non-classical base pairing interaction. Typically, the base pair is a Watson-Crick base pair, for example, AT (or AU) with two hydrogen bonds and CG with three hydrogen bonds.

[0034] As used herein, "complementary" refers to the ability of one nucleic acid to form base pairs with another nucleic acid. Typically, one strand is arranged 5'→3' and pairs with complementary nucleotides in the second strand in the 3'→5' direction. For example, 5'-GAATC-3' is complementary to 5'-GATTC-3' (i.e., 3'-CTTAG-5') and can form a double-stranded nucleic acid in which each nucleotide forms a Watson-Crick base pair with its corresponding complementary nucleotide on the other strand.

[0035] As used herein, the term "overlap" refers to a double-stranded nucleic acid having a non-base-paired nucleotide (e.g., "overhang") at one or both of the 5'-terminus or the 3'-terminus, which is capable of base pairing with a complementary non-base-paired nucleotide (e.g., "complementary overhang") at one or both of the 5'-terminus or the 3'-terminus of another double-stranded sequence. Figure 2A-2B , which shows a double-stranded DNA molecule with an overhanging single strand that overlaps and complements other different double-stranded molecules with overhanging single strands. In this way, multiple different double-stranded molecules with overhanging single strands at the 5′-end, 3′-end, or both can be assembled to form a long, non-covalently linked double-stranded DNA molecule. See Figure 2A .

[0036] As an illustrative example, a plurality of different dsDNA fragments may contain four dsDNA fragments F1, F2, F3, and F4, each with a top strand oriented 5'→3'. To assemble a long dsDNA, fragment F1 will have a 3'-end that overlaps with the 5'-end of F2. F2 will have a 5'-end that overlaps with the 3'-end of F1 and a 3'-end that overlaps with the 5'-end of F3. Similarly, F3 will have a 5'-end that overlaps with the 3'-end of F2 and a 3'-end that overlaps with the 5'-end of F4. F4 will have a 5'-end that overlaps with the end of F3.

[0037] As used herein, the term "long nucleic acid" or "large nucleic acid" refers to a nucleic acid greater than 100 nucleotides (or "base pairs" for double-stranded nucleic acids). This includes single-stranded nucleic acids, double-stranded nucleic acids, plasmids, vectors, or other constructs known in the art. Long nucleic acids can be 100 to 20,000 nucleotides or more, including all integers and subranges within the specified range. For example, long nucleic acids can include 100-1000, 100-5000, 500-2000, 1000-5000 nucleotides, or other subranges within 100-20,000 nucleotides.

[0038] As used herein, the term "different" refers to double-stranded DNA molecules or "fragments" having different nucleotide sequences. For example, "multiple different dsDNA fragments" refers to multiple dsDNA molecules each having a specific sequence. In a multiple mixture, multiple copies of each different dsDNA molecule may exist, together forming multiple different dsDNA fragments. As used herein, different dsDNA fragments may have a sequence at one or both of the 5'-end or 3'-end that can base pair with a complementary nucleotide at one or both of the 5'-end or 3'-end of another "independent" different dsDNA fragment (once the complementary region is converted to a single strand). As used herein, the term "independent" refers to different dsDNA fragments having different dsDNA sequences compared to another different dsDNA fragment.

[0039] Described herein are methods and compositions for improving DNA assembly of long double-stranded nucleic acid molecules using a combination of in vitro alignment and in vivo methods. The methods are improved relative to the current state of the art.

[0040] This paper describes the method for creating a large recombinant plasmid in a competent host cell using a plurality of DNA fragments containing sequences overlapping with adjacent fragments and a composition for the method. In one aspect, the method and composition can be used for the assembling of two or more double-stranded DNA fragments, and the assembly uses an exonuclease and a recombinase that can create a single-stranded protrusion from double-stranded DNA to catalyze and stabilize the complementary base pairing of a single-stranded (ssDNA) end. This makes it possible for the dsDNA assembly of multiple fragments without the need for a ligase or polymerase. Although these assemblies are not covalently linked, the stabilization of the recombinase to the overlapping region enables transformation into Escherichia coli, and is subsequently connected and replicated by a cell machine. In one aspect, the method comprises using a recombinase to stabilize the complementary region to allow transformation into the cell and subsequently replicate the DNA to create a dsDNA replica.

[0041] Also described herein are methods and compositions for assembling double-stranded (dsDNA) fragments using recombinase proteins. In one aspect, the methods and compositions can be used for the assembly of two or more double-stranded DNA fragments using RecA to catalyze complementary base pairing at the ends of single-stranded DNA (ssDNA) in an ATP-dependent manner, such that when performed in the presence of an exonuclease and optionally a polymerase and a ligase, multi-fragmented dsDNA assembly can be performed.

[0042] One embodiment described herein is a reaction mixture of a plurality of different dsDNA fragments containing sequences overlapping at least 10 base pairs with adjacent fragments, an exonuclease creating a single-stranded overhang of DNA, and a recombinase that promotes the hybridization of the newly created single strands and stabilization into a competent cell host. After hybridization incubation at a temperature between 25°C and 50°C for 5 to 120 minutes and subsequent inactivation incubation at 65°C for 5 to 120 minutes, the mixture is transformed into a competent host cell. After transformation and subsequent incubation, a covalently bound circular DNA molecule containing all overlapping fragments is obtained. In one aspect, the reaction mixture optionally contains a crowding agent and / or a chaperone. On the other hand, the covalently bound circular DNA molecule containing the overlapping fragments is then separated from the transformed cells. Exemplary methods include plasmid separation or directly using the cell as a target nucleic acid for PCR amplification. On the other hand, the sequence of the separated fragment is verified by Sanger sequencing or next generation sequencing (NGS). Another aspect described herein is a method for implementing a reaction mixture, a transformed cell, separating DNA, and sequencing the separated DNA.

[0043] One embodiment described herein is a reaction mixture of the following components: a plurality of different dsDNA fragments containing sequences that overlap adjacent fragments by 10 to 120 base pairs, an exonuclease that creates single-stranded overhangs of DNA, and a recombinase that promotes newly created single-stranded hybridization, a polymerase that fills the vacant single-stranded DNA after annealing promoted by the recombinase, and a ligase that covalently bonds the DNA fragments after filling. After initial incubation at a constant temperature, the mixture is transformed into competent host cells. After transformation, a covalently bound circular DNA molecule containing all overlapping fragments is obtained. In another aspect, the reaction mixture optionally also contains a crowding agent, including but not limited to polyethylene glycol (PEG). Another aspect described herein is a method of implementing a reaction mixture, transforming cells, isolating DNA, and sequencing the isolated DNA.

[0044] Another embodiment described herein is a mixture of the following components: multiple different dsDNA fragments containing sequences that overlap adjacent fragments by 10 to 120 base pairs, an exonuclease that creates single-stranded overhangs of DNA, and a recombinase that promotes newly created single-stranded hybridization, a polymerase that fills in the vacant single-stranded DNA after annealing promoted by the recombinase, and a ligase that covalently bonds the DNA fragments after filling. After an initial incubation at a constant temperature, the mixture is transformed into a competent host cell. After transformation, a covalently bound circular DNA molecule containing all overlapping fragments is obtained. In one aspect, the mixture optionally contains a chaperone, including but not limited to a diol or a polyol. Examples of diols or polyols include optionally substituted straight or branched chain alkylene glycols, pentaerythritol, sorbitol, diethylene glycol, dipropylene glycol, neopentyl glycol, such as propylene glycol and glycol ethers, such as 1,2-ethylene glycol, 1,2-PrD, 1,3-PrD, 1,4-butanediol, 1,5-pentanediol, 1,6-hexanediol, 2-methyl-1,3-propanediol, 2,2′-dimethylpropanediol, 1,3-butylethylpropanediol, methylpropanediol, methylpentanediol, propylene glycol methyl ether, propylene glycol ethyl ether, propylene glycol butyl ether, diethylene glycol phenyl ether, propylene glycol phenol ether, propylene glycol methyl ether, tripropylene glycol methyl ether, propylene glycol isobutyl ether, ethylene glycol methyl ether, or mixtures thereof. Another aspect described herein is a method of implementing a reaction mixture, transforming cells, isolating DNA, and sequencing the isolated DNA.

[0045] In one embodiment described herein, the recombinase protein comprises one or more of Uvsx from bacteriophage, Rad51 and Dmc1 from eukaryotes, RadA from archaea, or RecA from Escherichia coli. In another aspect, the recombinase protein is ATP-dependent. In another aspect, the recombinase is RecA or a recA ortholog containing a DNA binding domain and promoting DNA recombination.

[0046] In one embodiment described herein, the exonuclease is thermostable. In another aspect, the exonuclease is a 5′ to 3′ exonuclease or a 3′ to 5′ exonuclease. In another aspect, the exonuclease is a 3′ to 5′ exonuclease. In another aspect, the exonuclease is a T5 exonuclease.

[0047] In another embodiment described herein, the dsDNA nucleic acid fragment has overlapping ends. That is, the 5' end and 3' end of the adjacent fragment are complementary to each other. In one aspect, the overlapping ends are 5 to 100 base pairs (bp), including all integers in the specified range and the endpoints of the range. On the other hand, the overlapping ends are 5 bp, 10 bp, 15 bp, 20 bp, 25 bp, 30 bp, 35 bp, 40 bp, 45 bp, 50 bp, 55 bp, 60 bp, 65 bp, 70 bp, 75 bp, 80bp, 85 bp, 90 bp, 95 bp or 100 bp. On the other hand, the overlapping ends are between 10 bp and 60 bp. On the other hand, the overlapping ends are 20 bp, 25 bp, 30 bp, 35 bp, 40 bp, 45 bp or 50 bp.

[0048] In one embodiment, the incubation time of dsDNA and the reaction ranges from 10 minutes to 120 minutes, including all integers in the specified range and the endpoints of the range. On the other hand, the inactivation incubation time ranges from 10 minutes to 120 minutes, including all integers in the specified range and the endpoints of the range. On the other hand, the hybridization conditions include an incubation temperature ranging from about 25°C to about 50°C, including all integers in the specified range and the endpoints of the range. On the other hand, the inactivation conditions include an incubation temperature ranging from about 60°C to about 70°C, including all integers in the specified range and the endpoints of the range. On the other hand, the inactivation conditions include an incubation temperature of about less than 5°C.

[0049] One embodiment described herein is a method for assembling multiple double-stranded DNA (dsDNA) fragments into covalently bound circular dsDNA molecules, the method comprising: (a) combining multiple different dsDNA fragments with a reaction mixture comprising an exonuclease and a recombinase to form a DNA reaction mixture; wherein each individual dsDNA fragment comprises one or more terminal single-stranded nucleotides complementary to the terminal single-stranded nucleotides of the independent dsDNA fragment; (b) hybridizing and incubating the DNA reaction mixture to form a hybrid DNA reaction mixture; (c) incubating the hybrid DNA reaction mixture to form an inactivated DNA reaction mixture; (d) transforming the inactivated DNA reaction mixture into a competent host cell; and (e) incubating the transformed competent host cell under conditions sufficient to assemble and replicate one or more covalently bound circular dsDNA molecules comprising the multiple different dsDNA fragments. In one aspect, the recombinase is selected from Uvsx from bacteriophage, Rad51 or Dmc1 from eukaryotes, RadA from archaea, or RecA from Escherichia coli (E. coli). In another aspect, the recombinase is RecA from Escherichia coli. In another aspect, the reaction mixture further comprises ATP. In another aspect, the exonuclease is T5 exonuclease. In another aspect, the reaction mixture further comprises a DNA polymerase and a ligase. In another aspect, the competent host cell is an Escherichia coli cell. In another aspect, the complementary one or more terminal single-stranded nucleotides overlap the terminal single-stranded nucleotides of the independent dsDNA fragments by about 10 nucleotides to about 120 nucleotides. In another aspect, the complementary one or more terminal single-stranded nucleotides overlap the terminal single-stranded nucleotides of the independent dsDNA fragments by about 20 nucleotides to about 60 nucleotides. In another aspect, the complementary one or more terminal single-stranded nucleotides overlap the terminal single-stranded nucleotides of the independent dsDNA fragments by about 20 nucleotides to about 35 nucleotides. In another aspect, the complementary one or more terminal single-stranded nucleotides overlap the terminal single-stranded nucleotides of the independent dsDNA fragments by about 25 nucleotides to about 30 nucleotides. In another aspect, the hybridization incubation includes a hybridization temperature of about 25°C to about 50°C for about 5 minutes to about 120 minutes. In another aspect, the hybridization incubation comprises a hybridization temperature of about 35°C to about 45°C for about 10 minutes to about 20 minutes. In another aspect, the hybridization incubation comprises a hybridization temperature of about 42°C for about 20 minutes. In another aspect, the inactivation incubation comprises an inactivation temperature of about 60°C to about 70°C for about 5 minutes to about 120 minutes. In another aspect, the inactivation incubation comprises an inactivation temperature of about 65°C for about 20 minutes. In another aspect, the inactivation incubation comprises an inactivation temperature of less than about 5°C for about 20 minutes.In another aspect, the reaction mixture further comprises one or more crowding agents, one or more chaperones, or a combination thereof. In another aspect, the one or more crowding agents comprise polyethylene glycol (PEG). In another aspect, the one or more chaperones comprise a diol or polyol selected from the group consisting of substituted linear or branched alkylene glycols, pentaerythritol, sorbitol, diethylene glycol, dipropylene glycol, neopentyl glycol, propylene glycol and glycol ethers, 1,2-ethylene glycol, 1,2-PrD, 1,3-PrD, 1,4-butanediol, 1,5-pentanediol, 1,6-hexanediol, 2-methyl-1,3-propanediol, 2,2′-dimethylpropylene glycol, 1,3-butylethylpropylene glycol, methylpropylene glycol, methylpentanediol, propylene glycol methyl ether, propylene glycol ethyl ether, propylene glycol butyl ether, diethylene glycol phenyl ether, propylene glycol phenol ether, propylene glycol methyl ether, tripropylene glycol methyl ether, propylene glycol isobutyl ether, ethylene glycol methyl ether, or a combination thereof. In another aspect, the method further comprises isolating the covalently bound circular dsDNA molecules comprising the plurality of different dsDNA fragments from one or more competent host cells. In another aspect, the method further comprises sequencing the covalently bound circular DNA molecules comprising the plurality of different dsDNA fragments after isolating from the competent host cells.

[0050] Another embodiment described herein is a system for assembling multiple double-stranded DNA (dsDNA) fragments into covalently bound circular DNA molecules, the system comprising: (a) multiple different dsDNA fragments, wherein each individual dsDNA fragment comprises one or more terminal single-stranded nucleotides complementary to the terminal single-stranded nucleotides of the dsDNA fragments independent of the multiple different dsDNA fragments; (b) a reaction mixture comprising a nuclease and a recombinase; and (c) a competent host cell. On the other hand, the recombinase is selected from Uvsx from a bacteriophage, Rad51 or Dmc1 from a eukaryote, RadA from an archaea, or RecA from Escherichia coli. On the other hand, the recombinase is RecA from Escherichia coli. On the other hand, the reaction mixture further comprises ATP. On the other hand, the nuclease is T5 exonuclease. On the other hand, the reaction mixture further comprises a DNA polymerase and a ligase. On the other hand, the competent host cell is an Escherichia coli cell. On the other hand, the reaction mixture further comprises one or more crowding agents, one or more chaperones, or a combination thereof.

[0051] Another embodiment described herein is a kit for assembling multiple double-stranded DNA (dsDNA) fragments into covalently bound circular DNA molecules, the kit comprising: (a) an exonuclease; (b) a recombinase; (c) one or more buffers, crowding agents, or chaperones, or ATP; (d) optionally, a competent host cell; and (e) optionally, instructions or directions for use.

[0052] Another embodiment described herein is the use of exonucleases and recombinases for assembling multiple double-stranded DNA (dsDNA) fragments into covalently bound circular DNA molecules, comprising: (a) combining multiple different dsDNA fragments with a reaction mixture comprising an exonuclease and a recombinase to form a DNA reaction mixture, wherein each individual dsDNA fragment comprises one or more terminal single-stranded nucleotides complementary to the terminal single-stranded nucleotides of a dsDNA fragment independent of the multiple different dsDNA fragments; (b) incubating the DNA reaction mixture for hybridization to form a hybrid DNA reaction mixture; (c) incubating the hybrid DNA reaction mixture for inactivation to form an inactivated DNA reaction mixture; (d) transforming the inactivated DNA reaction mixture into a competent host cell; and (e) incubating the transformed competent host cell under conditions sufficient to assemble covalently bound circular DNA molecules comprising the multiple different dsDNA fragments.

[0053] It is obvious to those of ordinary skill in the relevant art that the compositions, formulations, methods, processes and applications described herein may be appropriately modified and adjusted without departing from the scope of any embodiment or aspect thereof. The compositions and methods provided are exemplary and are not intended to limit the scope of any specified embodiment. All various embodiments, aspects and options disclosed herein may be combined in any variation or iteration. The scope of the compositions, formulations, methods and processes described herein includes all actual or potential combinations of the embodiments, aspects, options, examples and preferences described herein. The exemplary compositions and formulations described herein may omit any component, replace any component disclosed herein, or include any component disclosed elsewhere herein. The ratio of the mass of any component of any composition or formulation disclosed herein to the mass of any other component in the formulation or to the total mass of other components in the formulation is hereby disclosed as if they were explicitly disclosed. If the meaning of any term in any patent or publication incorporated by reference conflicts with the meaning of the term used in the present disclosure, the meaning of the term or phrase in the present disclosure shall prevail. In addition, the above discussion only discloses and describes exemplary embodiments. All patents and publications cited herein are incorporated herein by reference for their specific teachings.

[0054] The various embodiments and aspects of the invention described herein are summarized by the following clauses:

[0055] Clause 1. A method of assembling a plurality of double-stranded DNA (dsDNA) fragments into a covalently bound circular dsDNA molecule, the method comprising:

[0056] (a) combining a plurality of different dsDNA fragments with a reaction mixture comprising an exonuclease and a recombinase to form a DNA reaction mixture;

[0057] wherein each individual dsDNA fragment comprises one or more terminal single-stranded nucleotides that are complementary to the terminal single-stranded nucleotide of the independent dsDNA fragment;

[0058] (b) subjecting the DNA reaction mixture to hybridization incubation to form a hybridized DNA reaction mixture;

[0059] (c) subjecting the hybridized DNA reaction mixture to an inactivation incubation to form an inactivated DNA reaction mixture;

[0060] (d) transforming the inactivated DNA reaction mixture into competent host cells; and

[0061] (e) incubating the transformed competent host cell under conditions sufficient for assembly and replication of one or more covalently bound circular dsDNA molecules comprising the plurality of different dsDNA fragments.

[0062] Clause 2. The method according to claim 1, wherein the recombinase is selected from Uvsx from bacteriophage, Rad51 or Dmc1 from eukaryotes, RadA from archaea, or RecA from Escherichia coli.

[0063] Clause 3. The method according to claim 2, wherein the recombinase is RecA from Escherichia coli.

[0064] Clause 4. The method of claim 1, wherein the reaction mixture further comprises ATP.

[0065] Clause 5. The method of claim 1 , wherein the exonuclease is T5 exonuclease.

[0066] Clause 6. The method of claim 1, wherein the reaction mixture further comprises a DNA polymerase and a ligase.

[0067] Clause 7. The method of claim 1, wherein the competent host cell is an Escherichia coli cell.

[0068] Clause 8. The method of claim 1, wherein the complementary one or more terminal single-stranded nucleotides overlap with the terminal single-stranded nucleotides of the independent dsDNA fragments by about 10 nucleotides to about 120 nucleotides.

[0069] Clause 9. The method of claim 8, wherein the complementary one or more terminal single-stranded nucleotides overlap with the terminal single-stranded nucleotides of the independent dsDNA fragments by about 20 nucleotides to about 60 nucleotides.

[0070] Clause 10. The method of claim 9, wherein the complementary one or more terminal single-stranded nucleotides overlap with the terminal single-stranded nucleotides of the independent dsDNA fragments by about 20 nucleotides to about 35 nucleotides.

[0071] Item 11. The method of claim 10, wherein the complementary one or more terminal single-stranded nucleotides overlap with the terminal single-stranded nucleotides of the independent dsDNA fragments by about 25 nucleotides to about 30 nucleotides.

[0072] Clause 12. The method of claim 1, wherein the hybridization incubation comprises a hybridization temperature of about 25°C to about 50°C for about 5 minutes to about 120 minutes.

[0073] Clause 13. The method of claim 12, wherein the hybridization incubation comprises a hybridization temperature of about 35°C to about 45°C for about 10 minutes to about 20 minutes.

[0074] Clause 14. The method of claim 13, wherein the hybridization incubation comprises a hybridization temperature of about 42°C for about 20 minutes.

[0075] Clause 15. The method of claim 1, wherein the inactivation incubation comprises an inactivation temperature of about 60°C to about 70°C for about 5 minutes to about 120 minutes.

[0076] Clause 16. The method of claim 15, wherein the inactivation incubation comprises an inactivation temperature of about 65°C for about 20 minutes.

[0077] Clause 17. The method of claim 1, wherein the inactivation incubation comprises an inactivation temperature below about 5°C for about 20 minutes.

[0078] Clause 18. The method of claim 1, wherein the reaction mixture further comprises one or more crowding agents, one or more chaperones, or a combination thereof.

[0079] Clause 19. The method of claim 18, wherein the one or more crowding agents comprises polyethylene glycol (PEG).

[0080] Clause 20. The method of claim 18, wherein the one or more chaperones comprise a diol or polyol selected from the group consisting of substituted linear or branched alkylene glycols, pentaerythritol, sorbitol, diethylene glycol, dipropylene glycol, neopentyl glycol, propylene glycol and glycol ethers, 1,2-ethanediol, 1,2-PrD, 1,3-PrD, 1,4-butanediol, 1,5-pentanediol, 1,6-hexanediol, 2-methyl-1,3-propanediol, 2,2′-dimethylpropanediol, 1,3-butylethylpropanediol, methylpropanediol, methylpentanediol, propylene glycol methyl ether, propylene glycol ethyl ether, propylene glycol butyl ether, diethylene glycol phenyl ether, propylene glycol phenol ether, propylene glycol methyl ether, tripropylene glycol methyl ether, propylene glycol isobutyl ether, ethylene glycol methyl ether, or combinations thereof.

[0081] Clause 21. The method of claim 1, further comprising isolating the covalently bound circular dsDNA molecules comprising the plurality of different dsDNA fragments from one or more competent host cells.

[0082] Clause 22. The method of claim 21, further comprising sequencing the covalently bound circular DNA molecules comprising the plurality of different dsDNA fragments after isolation from the competent host cell.

[0083] Clause 23. A system for assembling a plurality of double-stranded DNA (dsDNA) fragments into covalently bound circular DNA molecules, the system comprising:

[0084] (a) a plurality of different dsDNA fragments, wherein each individual dsDNA fragment comprises one or more terminal single-stranded nucleotides that are complementary to the terminal single-stranded nucleotides of a dsDNA fragment independent of the plurality of different dsDNA fragments; (b) a reaction mixture comprising an exonuclease and a recombinase; and (c) a competent host cell.

[0085] Clause 24. The system according to claim 23, wherein the recombinase is selected from Uvsx from bacteriophage, Rad51 or Dmc1 from eukaryotes, RadA from archaea, or RecA from Escherichia coli.

[0086] Clause 25. The system according to claim 24, wherein the recombinase is RecA from Escherichia coli.

[0087] Clause 26. The system of claim 23, wherein the reaction mixture further comprises ATP.

[0088] Clause 27. The system of claim 23, wherein the exonuclease is T5 exonuclease.

[0089] Clause 28. The system of claim 23, wherein the reaction mixture further comprises a DNA polymerase and a ligase.

[0090] Clause 29. The system of claim 23, wherein the competent host cell is an Escherichia coli cell.

[0091] Clause 30. The system of claim 23, wherein the reaction mixture further comprises one or more crowding agents, one or more chaperones, or a combination thereof.

[0092] Clause 31. A kit for assembling a plurality of double-stranded DNA (dsDNA) fragments into a covalently bound circular DNA molecule, the kit comprising:

[0093] (a) Exonucleases;

[0094] (b) recombinase;

[0095] (c) one or more buffers, crowding agents, or chaperones, or ATP;

[0096] (d) optionally, a competent host cell; and

[0097] (e) Optionally, instructions for use or directions.

[0098] Clause 32. Use of an exonuclease and a recombinase for assembling a plurality of double-stranded DNA (dsDNA) fragments into a covalently bound circular DNA molecule, comprising:

[0099] (a) combining a plurality of different dsDNA fragments with a reaction mixture comprising an exonuclease and a recombinase to form a DNA reaction mixture, wherein each individual dsDNA fragment comprises one or more terminal single-stranded nucleotides that are complementary to a terminal single-stranded nucleotide of a dsDNA fragment independent of the plurality of different dsDNA fragments;

[0100] (b) subjecting the DNA reaction mixture to hybridization incubation to form a hybridized DNA reaction mixture;

[0101] (c) subjecting the hybridized DNA reaction mixture to an inactivation incubation to form an inactivated DNA reaction mixture;

[0102] (d) transforming the inactivated DNA reaction mixture into competent host cells; and

[0103] (e) incubating the transformed competent host cell under conditions sufficient to assemble covalently bound circular DNA molecules comprising the plurality of different dsDNA fragments.

[0104] Example

[0105] Example 1

[0106] Ligase, polymerase and exonuclease assembly

[0107] This example shows dsDNA assembly using a reaction mixture comprising an exonuclease, a polymerase, and a ligase.

[0108] Multiple different dsDNA fragments with overlapping homologous ends were designed. See Table 1. 35 to 70 fmol of dsDNA fragments were added to a 20 µL reaction mixture containing 100 mM Tris·HCl, 10 mM MgCl2, 10 mM DTT, 1 M D-sorbitol, 0.8 mM dNTPs, 0.004 U / µL T5 exonuclease, 0.025 U / µL polymerase, 0.2675 U / µL ligase, 43 ng / µL. The multiple different dsDNA fragments and reaction mixture were incubated at 50°C for 20 minutes, followed by incubation at 65°C for 20 minutes. After incubation, the reactions were transferred into competent E. coli DH5α cells and transformed via chemical transformation.

[0109]

[0110]

[0111]

[0112] In this experiment, five linear double-stranded DNA fragments were combined as described above. When correctly assembled, the fragments created a pUC-based plasmid expressing green fluorescent protein (GFP). Evidence of correct assembly was demonstrated by resistance to ampicillin and the fluorescent phenotype of bacterial colonies when grown on LB agar plates (1% peptone, 0.5% yeast extract, 0.5% NaCl, 1.2% agar; 100 μg / mL ampicillin).

[0113] The transformation step involved transferring 2 µL of the incubation reaction mixture to 15 µL of competent cells, followed by transformation using heat shock at 42°C for 30 seconds. After transformation, 125 µL of SOC medium (2% tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4, and 20 mM glucose) was added to the heat shocked cells, followed by incubation at 37°C for 1 hour. After incubation at 37°C, the transformed cells and SOC medium mixture were plated on LB agar plates and incubated at 37°C for 16 hours. After the plate incubation, the total cells were counted and the cells expressing the fluorescent protein were counted.

[0114] Figure 3-Figure 5 Total colony counts, fluorescent colony counts and percentage of fluorescent colonies are shown, respectively. The first bar of each graph shows the counts for the assembly mixture without recombinase (ie, the reaction mixture contained exonuclease, polymerase and ligase).

[0115] Example 2

[0116] Recombinase, ligase, polymerase and exonuclease assembly

[0117] This example shows dsDNA assembly using a reaction mixture comprising a recombinase, an exonuclease, a polymerase, and a ligase.

[0118] Multiple different dsDNA fragments with overlapping homologous ends were designed. See Table 1 above. 35 to 70 fmol of dsDNA fragments were added to a 20 µL reaction mixture containing 100 mM Tris·HCl, 10 mM MgCl2, 10 mM DTT, 1 M D-sorbitol, 0.8 mM dNTPs, 0.004 U / µL T5 exonuclease, 0.025 U / µL polymerase, 0.2675 U / µL ligase, 43 ng / µL RecA, and 430 mM ATP. The multiple different dsDNA fragments and reaction mixture were incubated at 50°C for 20 minutes, followed by incubation at 65°C for 20 minutes. After incubation, the reaction was transferred to competent E. coli DH5α cells via chemical transformation.

[0119] Five linear double-stranded DNA fragments were combined as described in Example 1; see Table 1 above. When assembled correctly, the fragments created a pUC-based plasmid expressing green fluorescent protein (GFP). Evidence of correct assembly was indicated by resistance to ampicillin and the fluorescent phenotype of bacterial colonies when grown on LB agar plates. The transformation step included transferring 2 μL of the incubation reaction mixture to 15 μL of competent cells, followed by transformation using a heat shock at 42°C for 30 seconds. After transformation, 125 μL of SOC medium was added to the heat shocked cells, followed by incubation at 37°C for 1 hour. After incubation at 37°C, the transformed cells and SOC medium mixture were plated on LB agar plates and incubated at 37°C for 16 hours. After the plate incubation, the total cells were counted and the cells expressing the fluorescent protein were counted.

[0120] Figure 3-Figure 5 Total colony count, fluorescent colony count and fluorescent colony percentage are shown respectively. The second bar of each figure shows the count of the assembly mixture containing the recombinase. In addition, compared with the reaction mixture without the recombinase (as shown in the first bar of each figure), the second bar of each figure shows the improved assembly.

[0121] Example 3

[0122] Recombinase and exonuclease assembly

[0123] This example shows a dsDNA assembly technique using a reaction mixture containing an exonuclease and a recombinase. The reaction mixture in this example does not contain a ligase or a polymerase.

[0124] Multiple different dsDNA fragments with overlapping homologous ends were designed. See Table 1 above. 35-70 fmol of dsDNA fragments were added to a 20 µL reaction isothermal assembly reaction mixture containing 100 mM Tris·HCl, 10 mM MgCl2, 10 mM DTT, 1 M D-sorbitol, 0.8 mM dNTPs, 0.004 U / µL T5 exonuclease, 43 ng / µL RecA, and 430 mM ATP. The multiple different dsDNA fragments and isothermal assembly reaction mixture were incubated in a thermal cycler at 50°C for 20 minutes, followed by incubation at 65°C for 20 minutes. After incubation, the reaction mixture was transferred into DH5α E. coli cells via chemically competent transformation as described in Example 2.

[0125] Figure 3-Figure 5 Total colony counts, fluorescent colony counts and percentage of fluorescent colonies are shown, respectively. The third bar of each graph shows the counts for the assembly mix with recombinase and exonuclease (ie, no polymerase or ligase was included).

[0126] Figure 3-Figure 5 It is shown that the recombinase and exonuclease assembly mixture resulted in an increase in total colony counts, fluorescent colony counts, and percentage of fluorescent colonies when compared to a reaction mixture containing an exonuclease, polymerase, and ligase (as shown in the first bar of each graph) and a reaction mixture containing a recombinase, exonuclease, polymerase, and ligase (as shown in the second bar of each graph).

[0127] Example 4

[0128] Recombinase and exonuclease assembly - heat denaturation

[0129] This example shows that hybridization between ssDNA ends and interaction with the recombinase is non-covalent and can be disrupted by heat denaturation.

[0130] Reactions were prepared as described in Example 3. Reactions were incubated in a thermal cycler at 50°C for 20 min and at 65°C for 20 min, with or without a 2 min 95°C heat denaturation step. Without a 2 min 95°C heat denaturation step, the 65°C incubation was extended for 2 min. After incubation, the reaction mixture was transferred to competent DH5α E. coli cells via chemical transformation as described in Example 2.

[0131] Figure 6 Heat denaturation prior to transformation is shown to disrupt hybridization and interaction with the recombinase.

[0132] Example 5

[0133] Recombinase and exonuclease assembly - temperature testing

[0134] This example shows the efficiency of the assembly recombinase and exonuclease assembly methods at different hybridization incubation temperatures.

[0135] The reaction mix composition was set up as previously described in Example 3 (the reaction mixture contained recombinase and exonuclease, no polymerase or ligase). The various dsDNA fragments and reaction mixtures were incubated in a thermal cycler at 25°C, 37°C, 42°C, or 50°C for 20 min, followed by incubation at 65°C for 20 min. After incubation, the samples were transformed as described in Example 2.

[0136] Figure 7 The assembly reaction mixture was shown to function at multiple incubation temperatures.

[0137] Example 6

[0138] Recombinase and exonuclease assembly overhang test

[0139] This example shows the effect of varying overhang length on dsDNA fragments. dsDNA fragments were designed so that the overhangs on the 3'-end and 5'-end of adjacent dsDNA fragments contained 15 bp, 20 bp, 25 bp, 30 bp or 35 bp with complementarity.

[0140]

[0141]

[0142]

[0143]

[0144]

[0145] The reaction mix composition was set up as previously described in Example 3. The multiple different dsDNA fragments and reaction mixture were incubated as previously described in Example 2 and transformed as previously described in Example 1.

[0146] Figure 8 Different protrusion lengths that can be used in the assembly reaction are shown.

Claims

1. A method for assembling a plurality of double-stranded DNA (dsDNA) fragments into a covalently bound circular dsDNA molecule, the method comprising: (a) combining a plurality of different dsDNA fragments with a reaction mixture comprising an exonuclease and a recombinase to form a DNA reaction mixture; wherein each individual dsDNA fragment comprises one or more terminal single-stranded nucleotides that are complementary to the terminal single-stranded nucleotide of the independent dsDNA fragment; (b) subjecting the DNA reaction mixture to hybridization incubation to form a hybridized DNA reaction mixture; (c) subjecting the hybridized DNA reaction mixture to an inactivation incubation to form an inactivated DNA reaction mixture; (d) transforming the inactivated DNA reaction mixture into competent host cells; and (e) incubating the transformed competent host cell under conditions sufficient for assembly and replication of one or more covalently bound circular dsDNA molecules comprising the plurality of different dsDNA fragments.

2. The method according to claim 1, wherein the recombinase is selected from Uvsx from bacteriophage, Rad51 or Dmc1 from eukaryotes, RadA from archaea or RecA from Escherichia coli (E. coli). The method according to claim 2 , wherein the recombinase is RecA from Escherichia coli. The method of claim 1 , wherein the reaction mixture further comprises ATP. The method of claim 1 , wherein the exonuclease is T5 exonuclease. The method of claim 1 , wherein the reaction mixture further comprises a DNA polymerase and a ligase. The method according to claim 1 , wherein the competent host cell is an Escherichia coli cell.

8. The method of claim 1, wherein the complementary one or more terminal single-stranded nucleotides overlap with the terminal single-stranded nucleotides of the independent dsDNA fragments by about 10 nucleotides to about 120 nucleotides.

9. The method of claim 8, wherein the complementary one or more terminal single-stranded nucleotides overlap with the terminal single-stranded nucleotides of the independent dsDNA fragments by about 20 nucleotides to about 60 nucleotides.

10. The method of claim 9, wherein the complementary one or more terminal single-stranded nucleotides overlap with the terminal single-stranded nucleotides of the independent dsDNA fragments by about 20 nucleotides to about 35 nucleotides.

11. The method of claim 10, wherein the complementary one or more terminal single-stranded nucleotides overlap with the terminal single-stranded nucleotides of the independent dsDNA fragments by about 25 nucleotides to about 30 nucleotides.

12. The method of claim 1, wherein the hybridization incubation comprises a hybridization temperature of about 25°C to about 50°C for about 5 minutes to about 120 minutes.

13. The method of claim 12, wherein the hybridization incubation comprises a hybridization temperature of about 35°C to about 45°C for about 10 minutes to about 20 minutes.

14. The method of claim 13, wherein the hybridization incubation comprises a hybridization temperature of about 42°C for about 20 minutes.

15. The method of claim 1, wherein the inactivation incubation comprises an inactivation temperature of about 60°C to about 70°C for about 5 minutes to about 120 minutes.

16. The method of claim 15, wherein the inactivation incubation comprises an inactivation temperature of about 65°C for about 20 minutes.

17. The method of claim 1, wherein the inactivation incubation comprises an inactivation temperature below about 5°C for about 20 minutes.

18. The method of claim 1, wherein the reaction mixture further comprises one or more crowding agents, one or more chaperones, or a combination thereof.

19. The method of claim 18, wherein the one or more crowding agents comprises polyethylene glycol (PEG).

20. The method of claim 18, wherein the one or more chaperones comprise a diol or polyol selected from the group consisting of substituted linear or branched alkylene glycols, pentaerythritol, sorbitol, diethylene glycol, dipropylene glycol, neopentyl glycol, propylene glycol and glycol ethers, 1,2-ethylene glycol, 1,2-PrD, 1,3-PrD, 1,4-butanediol, 1,5-pentanediol, 1,6-hexanediol, 2-methyl-1,3-propanediol, 2,2′-dimethylpropylene glycol, 1,3-butylethylpropylene glycol, methylpropylene glycol, methylpentanediol, propylene glycol methyl ether, propylene glycol ethyl ether, propylene glycol butyl ether, diethylene glycol phenyl ether, propylene glycol phenol ether, propylene glycol methyl ether, tripropylene glycol methyl ether, propylene glycol isobutyl ether, ethylene glycol methyl ether, or combinations thereof.

21. The method of claim 1, further comprising isolating the covalently bound circular dsDNA molecules comprising the plurality of different dsDNA fragments from one or more competent host cells.

22. The method of claim 21, further comprising sequencing the covalently bound circular DNA molecules comprising the plurality of different dsDNA fragments after isolation from the competent host cell.

23. A system for assembling a plurality of double-stranded DNA (dsDNA) fragments into covalently bound circular DNA molecules, the system comprising: (a) a plurality of different dsDNA fragments, wherein each individual dsDNA fragment comprises one or more terminal single-stranded nucleotides that are complementary to a terminal single-stranded nucleotide of a dsDNA fragment independent of the plurality of different dsDNA fragments; (b) a reaction mixture comprising an exonuclease and a recombinase; and (c) Competent host cells.

24. The system according to claim 23, wherein the recombinase is selected from Uvsx from bacteriophage, Rad51 or Dmc1 from eukaryotes, RadA from archaea or RecA from Escherichia coli.

25. The system according to claim 24, wherein the recombinase is RecA from Escherichia coli.

26. The system of claim 23, wherein the reaction mixture further comprises ATP.

27. The system of claim 23, wherein the exonuclease is T5 exonuclease.

28. The system of claim 23, wherein the reaction mixture further comprises a DNA polymerase and a ligase.

29. The system of claim 23, wherein the competent host cells are E. coli cells.

30. The system of claim 23, wherein the reaction mixture further comprises one or more crowding agents, one or more chaperones, or a combination thereof.

31. A kit for assembling a plurality of double-stranded DNA (dsDNA) fragments into a covalently bound circular DNA molecule, the kit comprising: (a) Exonucleases; (b) recombinase; (c) one or more buffers, crowding agents, or chaperones, or ATP; (d) optionally, a competent host cell; and (e) Optionally, instructions for use or directions.

32. Use of an exonuclease and a recombinase for assembling a plurality of double-stranded DNA (dsDNA) fragments into a covalently bound circular DNA molecule, comprising: (a) combining a plurality of different dsDNA fragments with a reaction mixture comprising an exonuclease and a recombinase to form a DNA reaction mixture, wherein each individual dsDNA fragment comprises one or more terminal single-stranded nucleotides that are complementary to a terminal single-stranded nucleotide of a dsDNA fragment independent of the plurality of different dsDNA fragments; (b) subjecting the DNA reaction mixture to hybridization incubation to form a hybridized DNA reaction mixture; (c) subjecting the hybridized DNA reaction mixture to an inactivation incubation to form an inactivated DNA reaction mixture; (d) transforming the inactivated DNA reaction mixture into competent host cells; and (e) incubating the transformed competent host cell under conditions sufficient to assemble covalently bound circular DNA molecules comprising the plurality of different dsDNA fragments.